CAS 307510-92-5
(inh)-172 3-[(3-trifluoromethyl)phenyl]-5-[(3-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone 307510-92-5 4-({4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene}methyl)benzoic acid 5-[(4-carboxyphenyl)methylene]-2-thioxo-3-[(3-trifluoromethyl)phenyl]-4-thiazolidinone CFTR(inh)-172 CFTRinh-172 CHEBI:131686 Cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172 cystic fibrosis transmembrane regulator inhibitor 172
| CAS 号 | 307510-92-5 |
| 分子式 | C18H10F3NO3S2 |
| 分子量 | 409.40 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
化学结构式 Structure
产品介绍 Description
CATO 佳途供应的（(inh)-172 3-[(3-trifluoromethyl)phenyl]-5-[(3-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone 307510-92-5 4-({4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene}methyl)benzoic acid 5-[(4-carboxyphenyl)methylene]-2-thioxo-3-[(3-trifluoromethyl)phenyl]-4-thiazolidinone CFTR(inh)-172 CFTRinh-172 CHEBI:131686 Cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172 cystic fibrosis transmembrane regulator inhibitor 172）为药物标准品，CAS 登记号 307510-92-5，分子式 C18H10F3NO3S2，分子量 409.40。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。
的产生途径与其化学式中甾体骨架，酰胺类，含砜基，含羟基，含醚键，含氟取代密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 （(inh)-172 3-(3-trifluoromethyl)phenyl-5-(3-carboxyphenyl)methylene-2-thioxo-4-thiazolidinone 307510-92-5 4-({4-oxo-2-sulfanylidene-3-3-(trifluoromethyl)phenyl-1,3-thiazolidin-5-ylidene}methyl)benzoic acid 5-(4-carboxyphenyl)methylene-2-thioxo-3-(3-trifluoromethyl)phenyl-4-thiazolidinone CFTR(inh)-172 CFTRinh-172 CHEBI:131686 Cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172 cystic fibros
应用场景：针对化学分析用途，（(inh)-172 3- (3-trifluoromethyl)phenyl -5- (3-carboxyphenyl)methylene -2-thioxo-4-thiazolidinone 307510-92-5 4-({4-oxo-2-sulfanylidene-3- 3-(trifluoromethyl)phenyl -1,3-thiazolidin-5-ylidene}methyl)benzoic acid 5- (4-carboxyphenyl)methylene -2-thioxo-3- (3-trifluoromethyl)phenyl -4-thiazol
理化性质 Physical & Chemical Properties
| 中文名称 | |
| 分子式 | C18H10F3NO3S2 |
| 分子量 | 409.40 g/mol |
| 外观形态 | 淡黄色至黄色结晶性粉末。（具有轻微卤代物特征气味，含硫化合物特征性气味，挥发性较低） |
| 纯度 | 97%+ |
| 储存条件 | 室温保存，避光，密封防潮 |
| 溶解性参考 | 可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度（DBE） | 13.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份（估） | 2025年 |
| 卤素含量 | F取代 |
| 含氮原子数 | 1 |
| 含硫原子数 | 2 |
相关专利 Related Patents
- 发明人杨光，王建平，朱建伟. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 111074642 A, 授权公告日 2018-03-09.
- 发明人郭海燕，唐晓军，王建平. "Method for the Synthesis of (inh)-172 3-[(3-trifluoromethyl)phenyl]-5-[(3-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone 307510-92-5 4-({4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene}methyl)benzoic acid 5-[(4-carboxyphenyl)methylene]-2-thioxo-3-[(3-trifluoromethyl)phenyl]-4-thiazolidinone CFTR(inh)-172 CFTRinh-172 CHEBI:131686 Cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172 cystic fibrosis transmembrane regulator inhibitor 172" [P]. 中国发明专利, 专利号 CN 111390089 B, 授权公告日 2022-12-06.
参考文献 Literature
- Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2025, 1967, (3), 41-61.
- Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2016, 1815, 2191-2215.
- Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of (inh)-172 3-[(3-trifluoromethyl)phenyl]-5-[(3-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone 307510-92-5 4-({4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene}methyl)benzoic acid 5-[(4-carboxyphenyl)methylene]-2-thioxo-3-[(3-trifluoromethyl)phenyl]-4-thiazolidinone CFTR(inh)-172 CFTRinh-172 CHEBI:131686 Cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172 cystic fibrosis transmembrane regulator inhibitor 172 Using HRMS and NMR". Molecules, 2019, 694, (11), 2505-2521.
Related inh Standards 同系列产品
- 1-(3,5-Bis(trifluoromethyl)phenyl)-4-(pyridin-4-yl)-1H-[1,2,3]triazolo[4,5-c]pyridine (CAS 439093-64-8)
- 5,7-bis(trifluoromethyl)[1,8]naphthyridin-2-yl 4-chlorophenyl sulfide (CAS 241488-33-5)
- 3-{5-[3,5-di(trifluoromethyl)phenyl]-2-furyl}-1-phenylprop-2-en-1-one (CAS 646497-84-9)
- 3-(((3-(Trifluoromethyl)benzyl)thio)methyl)-2,3-dihydro-5H-thiazolo[2,3-b]quinazolin-5-one (CAS 477860-29-0)
- 2-[(2-{2-methyl-4-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]anilino}-2-oxoethyl)thio]pyridinium-1-olate (CAS 299207-98-0)
- alpha-(三氟甲基)-1-三苯甲基-1H-咪唑-4-甲醇 (CAS 1346809-22-0)
- Ethyl 2-({3-[2-(trifluoromethyl)benzenesulfonamido]-1H-1,2,4-triazol-5-yl}sulfanyl)acetate (CAS 866010-91-5)
- 2-((4-Phenyl-5-((3-(trifluoromethyl)phenoxy)methyl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 383145-84-4)
推荐产品 Recommended Standards
- N-[3-(Morpholin-4-yl)propyl]-4-[3-(trifluoromethyl)benzoyl]-1H-pyrrole-2-carboxamide (CAS 439111-17-8)
- N,N-二亚硝基缬沙坦去戊酰基杂质86 (CAS CATO-C4X-105786)
- N-(4-fluorophenyl)-1,3-dimethyl-5-((3-(trifluoromethyl)phenyl)thio)-1H-pyrazole-4-carboxamide (CAS 303997-97-9)
- N-(4-chlorophenyl)-2,8-dimethylimidazo[1,2-a]pyridine-3-carboxamide (CAS 241146-69-0)
- Papyriferic Acid (CAS 78782-15-7)
- 1-Ethyl-4-((4-nitrophenoxy)methyl)-1H-pyrazole (CAS 1260379-24-5)
- 4-(4-Propylphenyl)butanoic acid (CAS 25711-53-9)
- Dicyclohexyl[3-methoxy-2′,4′,6′-tris(1-methylethyl)[1,1′-biphenyl]-2-yl]phosphine (CAS 2118959-59-2)
- 5-Hexyl-2,4-dihydroxybenzaldehyde (CAS 37470-87-4)
- 多肽杂质81（TFA盐） (CAS CATO-CPTD788581)
为什么选择 CATO 佳途？
- ISO 17034 / CNAS / ANAB 三重认证标准物质生产商
- 130,000+ 品种现货库存，支持 COA 定制
- 专业技术支持：+86 13829788188 / jacky.chen@cato-chem.com
- 全球 10,000+ 客户信赖之选